相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Novel meningococcal 4CMenB vaccine antigens - prevalence and polymorphisms of the encoding genes in Neisseria gonorrhoeae
Ronza Hadad et al.
APMIS (2012)
The Factor H Binding Protein of Neisseria meningitidis Interacts with Xenosiderophores in Vitro
Daniele Veggi et al.
BIOCHEMISTRY (2012)
Immunogenicity and Tolerability of Recombinant Serogroup B Meningococcal Vaccine Administered With or Without Routine Infant Vaccinations According to Different Immunization Schedules A Randomized Controlled Trial
Nicoletta Gossger et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study
Maria Elena Santolaya et al.
LANCET (2012)
Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial
Peter C. Richmond et al.
LANCET INFECTIOUS DISEASES (2012)
Design and Evaluation of Meningococcal Vaccines through Structure-Based Modification of Host and Pathogen Molecules
Steven Johnson et al.
PLOS PATHOGENS (2012)
Characterization of Neisseria meningitidis Isolates That Do Not Express the Virulence Factor and Vaccine Antigen Factor H Binding Protein
Jay Lucidarme et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Characterization of Diverse Subvariants of the Meningococcal Factor H (fH) Binding Protein for Their Ability To Bind fH, To Mediate Serum Resistance, and To Induce Bactericidal Antibodies
Kate L. Seib et al.
INFECTION AND IMMUNITY (2011)
Molecular Characterization of the Interaction between Sialylated Neisseria gonorrhoeae and Factor H
Jutamas Shaughnessy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
A Meningococcal Factor H Binding Protein Mutant That Eliminates Factor H Binding Enhances Protective Antibody Responses to Vaccination
Peter T. Beernink et al.
JOURNAL OF IMMUNOLOGY (2011)
Rational Design of a Meningococcal Antigen Inducing Broad Protective Immunity
Maria Scarselli et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Characterization of fHbp, nhba (gna2132), nadA, porA, and Sequence Type in Group B Meningococcal Case Isolates Collected in England and Wales during January 2008 and Potential Coverage of an Investigational Group B Meningococcal Vaccine
Jay Lucidarme et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Virulence determinants involved in differential host niche adaptation of Neisseria meningitidis and Neisseria gonorrhoeae
Stephanie Schielke et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2010)
The Meningococcal Vaccine Candidate Neisserial Surface Protein A (NspA) Binds to Factor H and Enhances Meningococcal Resistance to Complement
Lisa A. Lewis et al.
PLOS PATHOGENS (2010)
Factor H-Binding Protein Is Important for Meningococcal Survival in Human Whole Blood and Serum and in the Presence of the Antimicrobial Peptide LL-37
K. L. Seib et al.
INFECTION AND IMMUNITY (2009)
Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates
Muriel C. Schneider et al.
NATURE (2009)
The modular architecture of meningococcal factor H-binding protein
Peter T. Beernink et al.
MICROBIOLOGY-SGM (2009)
Bactericidal antibody responses induced by meningococcal recombinant chimeric factor H-binding protein vaccines
Peter T. Beernink et al.
INFECTION AND IMMUNITY (2008)
Epidemic meningitis, meningococcaemia, and Neisseria meningitidis
David S. Stephens et al.
LANCET (2007)
Interactions between Neisseria meningitidis and the complement system
Muriel C. Schneider et al.
TRENDS IN MICROBIOLOGY (2007)
Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5-year olds in New Zealand
P. Oster et al.
VACCINE (2007)
Factor H binding and function in sialylated pathogenic neisseriae is influenced by gonococcal, but not meningococcal, porin
Guillermo Madico et al.
JOURNAL OF IMMUNOLOGY (2007)
Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines
Caroline L. Trotter et al.
FEMS MICROBIOLOGY REVIEWS (2007)
A universal vaccine for serogroup B meningococcus
Marzia M. Giuliani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance
Guillermo Madico et al.
JOURNAL OF IMMUNOLOGY (2006)
Functional significance of factor H binding to Neisseria meningitidis
Muriel C. Schneider et al.
JOURNAL OF IMMUNOLOGY (2006)
Available carbon source influences the resistance of Neisseria meningitidis against complement
RM Exley et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Vaccine potential of the Neisseria meningitidis 2086 lipoprotein
LD Fletcher et al.
INFECTION AND IMMUNITY (2004)
Neisseria meningitidis:: an overview of the carriage state
SP Yazdankhah et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2004)
The complement system in B cell regulation
MC Carroll
MOLECULAR IMMUNOLOGY (2004)
Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870
V Masignani et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Factor H family proteins: on complement, microbes and human diseases
PF Zipfel et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2002)
The Neisseria lipooligosaccharide-specific α-2,3-sialyltransferase is a surface-exposed outer membrane protein
DM Shell et al.
INFECTION AND IMMUNITY (2002)
Medical progress: Meningococcal disease.
NE Rosenstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
C4bp binding to porin mediates stable serum resistance of Neisseria gonorrhoeae
S Ram et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2001)
Binding of C4b-binding protein:: A molecular mechanism of serum resistance of Neisseria gonorrhoeae
S Ram et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Update on meningococcal disease with emphasis on pathogenesis and clinical management
M van Deuren et al.
CLINICAL MICROBIOLOGY REVIEWS (2000)
分享论文
